F.L. Putnam Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Buy
+4,387
New +$188K ﹤0.01% 625
2026
Q1
Sell
-4,717
Closed -$240K 603
2025
Q4
$240K Buy
+4,717
New +$241K ﹤0.01% 547
2025
Q3
Sell
-6,136
Closed -$424K 602
2025
Q2
$424K Buy
6,136
+1,070
+21% +$72.8K 0.01% 441
2025
Q1
$352K Sell
5,066
-629
-11% -$52K 0.01% 467
2024
Q4
$490K Sell
5,695
-897
-14% -$97K 0.01% 421
2024
Q3
$785K Buy
6,592
+1,391
+27% +$186K 0.01% 358
2024
Q2
$742K Buy
5,201
+283
+6% +$37.5K 0.01% 362
2024
Q1
$631K Buy
4,918
+8
+0.2% +$952 0.01% 309
2023
Q4
$508K Sell
4,910
-235
-5% -$23.2K 0.01% 332
2023
Q3
$468K Buy
5,145
+1
+0% +$88 0.01% 345
2023
Q2
$416K Buy
5,144
+414
+9% +$33.8K 0.01% 375
2023
Q1
$376K Buy
4,730
+682
+17% +$48.4K 0.01% 338
2022
Q4
$274K Buy
+4,048
New +$237K 0.01% 355
2022
Q2
Sell
-4,038
Closed -$224K 419
2022
Q1
$224K Sell
4,038
-1,534
-28% -$78.7K 0.01% 382
2021
Q4
$312K Hold
5,572
0.01% 332
2021
Q3
$267K Sell
5,572
-130
-2% -$6.29K 0.01% 346
2021
Q2
$239K Buy
+5,702
New +$221K 0.01% 374
2020
Q4
Sell
-5,858
Closed -$203K 332
2020
Q3
$203K Buy
+5,858
New +$195K 0.01% 292

Other funds holding NVO

F.L. Putnam Investment Management's NVO Position: Q2 2026 in Review

F.L. Putnam Investment Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,387 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #625 among its holdings. This is a return to the name: F.L. Putnam Investment Management previously reported a position in NVO as recently as Q4 2025.

F.L. Putnam Investment Management first reported a position in NVO in Q3 2020 and has held it in 18 quarters since. The position peaked at $785K in Q3 2024. 884 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • F.L. Putnam Investment Management held 4,387 shares of Novo Nordisk worth $210K as of Q2 2026.
  • Novo Nordisk was a new F.L. Putnam Investment Management position in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #625 holding.
  • F.L. Putnam Investment Management first reported a position in Novo Nordisk in Q3 2020 and has held it in 18 quarters since.
  • F.L. Putnam Investment Management's Novo Nordisk position peaked at $785K in Q3 2024.
  • 884 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.